Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit. READ MORE
The 40th Annual San Antonio Breast Cancer Symposium will take place from December 5-9 in the Henry B Gonzalez Convention Center. Breast cancer clinicians and researchers will convene to discuss cutting-edge treatment options and novel strategies for managing breast cancer.
Researchers conducted a study to generate estimates of costs associated with breast cancer adjuvant chemotherapy regimens.
Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit.
Weight loss was associated with a reduced risk for breast cancer among postmenopausal women.
Nearly one in five women with early-stage breast cancer received guideline-discordant treatment, usually with regards to chemotherapy use.
A 21-gene assay poses an overall incremental cost increase to the health care system in the short-term, despite lower rates of chemotherapy use.
Research in Review
Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy.
The American College of Obstetricians and Gynecologists has recently updated its clinical guidelines for the management of hereditary breast and ovarian cancer syndrome.